Department of TCMs Pharmaceuticals, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, PR China.
Beijing Haiyan Pharmaceutical Co., Ltd., Yangtze River Pharmaceutical Group, Beijing, 102206, PR China; Jiangsu Longfengtang Traditional Chinese Medicine Co., Ltd., Yangtze River Pharmaceutical Group, Taizhou, 225321, PR China.
J Ethnopharmacol. 2022 Jan 30;283:114664. doi: 10.1016/j.jep.2021.114664. Epub 2021 Sep 20.
Suhuang antitussive capsule (SH capsule), a typical traditional Chinese medicines (TCMs) compound, is widely used for the treatment of post-infectious cough (PIC) in the clinic. Our previous studies have demonstrated that SH capsule possesses significant ameliorative effects on cough variant asthma (CVA), sputum obstruction and airway remodeling.
This study is designed to investigate the ameliorative effects and potential mechanisms of SH capsule on PIC in mice.
To establish the PIC model, ICR mice were induced by lipopolysaccharide (LPS) (3 mg/kg) once, followed by cigarettes smoke (CS) exposure for 30 min per day for 30 days. Mice were intragastrically (i.g.) administrated with SH capsule at the doses of 3.5, 7, 14 g/kg each day for 2 weeks since the 24th day. The number of coughs, coughs latencies, enzyme-linked immunosorbent assay (ELISA) and histological analysis were used to investigate the effects of SH capsule on PIC mice. Quantitative-polymerase chain reaction (Q-PCR) and western blotting were conducted to evaluate the levels of mRNA and proteins associated with Aryl hydrocarbon receptor (AhR)-NF-E2-related factor 2 (Nrf2) pathway. Superoxide dismutase (SOD), glutathione (GSH) and total antioxidant capacity (T-AOC) assays were performed to evaluate the oxidative stress. A549 cells were used to investigate the ameliorative effects of SH capsule in vitro.
SH capsule effectively diminished the number of coughs and extended coughs latencies in PIC mice. The airway inflammation was alleviated by decreasing the expression levels of inflammatory mediators including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6). Moreover, SH capsule dose-dependently activated AhR-Nrf2 pathway and induced the nuclear translocation in vitro and in vivo. Besides, SH capsule significantly increased the levels of SOD, GSH and T-AOC in mice.
Our study demonstrates that SH capsule ameliorates airway inflammation-associated PIC in mice through activating AhR-Nrf2 pathway and consequently alleviating inflammatory responses and oxidative stress.
苏黄止咳胶囊(SH 胶囊)是一种典型的中药复方,临床上广泛用于治疗感染后咳嗽(PIC)。我们之前的研究表明,SH 胶囊对咳嗽变异性哮喘(CVA)、痰阻和气道重塑具有显著的改善作用。
本研究旨在探讨 SH 胶囊对 PIC 小鼠的改善作用及其潜在机制。
采用脂多糖(LPS)(3mg/kg)单次诱导、香烟烟雾(CS)每日 30min 暴露 30 天的方法建立 PIC 模型。自第 24 天起,2 周内每天给予 SH 胶囊 3.5、7、14g/kg 灌胃治疗。通过记录咳嗽次数、咳嗽潜伏期、酶联免疫吸附试验(ELISA)和组织学分析来研究 SH 胶囊对 PIC 小鼠的影响。采用实时定量聚合酶链反应(Q-PCR)和蛋白质印迹法(western blotting)检测与芳香烃受体(AhR)-核因子红细胞 2 相关因子 2(Nrf2)通路相关的 mRNA 和蛋白水平。通过超氧化物歧化酶(SOD)、谷胱甘肽(GSH)和总抗氧化能力(T-AOC)测定评估氧化应激。体外采用 A549 细胞进一步研究 SH 胶囊的改善作用。
SH 胶囊能有效减少 PIC 小鼠的咳嗽次数和延长咳嗽潜伏期。通过降低肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)和白细胞介素-6(IL-6)等炎症介质的表达水平,减轻气道炎症。此外,SH 胶囊呈剂量依赖性激活 AhR-Nrf2 通路,诱导其在体内外的核转位。此外,SH 胶囊还能显著提高小鼠体内 SOD、GSH 和 T-AOC 的水平。
本研究表明,SH 胶囊通过激活 AhR-Nrf2 通路,改善与气道炎症相关的 PIC,从而减轻炎症反应和氧化应激。